Current Employment:

Mount Sinai Comprehensive Cancer Center Attending Physician in Hematology and Oncology Co-Director, GI Program 7/04 - Present

Education and Training:

	Memorial Sloan-Kettering Cancer Center, New York, NY Fellow in Medical Oncology/Hematology, Department of Medicine 7/01-(6/04)
	Weill Medical College of Cornell University, New York, NY Fellow in Medicine 7/01-(6/04)
	Columbia-Presbyterian Hospital, New York, NY Internship and Residency in Internal Medicine 6/98- 7/01
	Mount Sinai School of Medicine, New York, NY MD received May, 1998 8/94- 5/98
	New York University, New York, NY Bachelor of Arts with Major in Biochemistry, Minor in Italian 9/90- 5/94

Honors and Awards:
Medical School:

Alpha Omega Alpha 1998

College:

	Phi Beta Kappa Society 1994
	Magna Cum Laude 1994
	Phi Lambda Upsilon Chemistry Honors Society 1992

Publications and Abstracts:

	Pizzolato JF, Saltz LB, "Irinotecan in the Treatment of Pancreatic Cancer", Expert Review of Anticancer Therapy, 3(5), 2003
	Pizzolato JF, Saltz LB, "The camptothecins", Lancet, 2003, 361(9376):2235-42.
	Tang HY, Zhao K, Pizzolato JF, Fonarev M, Langer JC, and Manfredi JJ, "Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53", J Biol Chem, 1998, 273, 29156-63.
	Pizzolato JF, Sharma S, Maki R, Krug M, Hammershaimb L, Pluda J, "Phase I study of Medi-522, an aVß3 integrin inhibitor, in patients with irinotecan-refractory colorectal cancer", Proceedings of ASCO 2003, A983.
	Pizzolato J, Greenberg D, Streeter G, Manfredi J, Arkin S, Benjamin D, and Tendler CL, "Mutant p53 in AIDS-Lymphoma Cell Lines is Associated With Resistance to Chemotherapy and Radiation-Induced Apoptosis", Blood, 1995,Vol 86 No 10 A2943.

Research Experience:

Memorial Sloan-Kettering Cancer Center, New York, NY - 7/02-(6/04) Investigation of novel treatments for colon and rectal cancers through the development of phase I and phase II studies. Our research focused on an incorporation of targeted agents into current standard treatments through an understanding of biological mechanisms.

The Mount Sinai School of Medicine, New York, NY - 10/94-5/96 Investigation of chemotherapeutic drugs and their effect on the p53 system in breast cancer cell lines under the direction of Dr. James Manfredi, Division of Medical Oncology, Department of Medicine. Research investigation involving p53 and Burkitt's lymphoma in AIDS patients under Dr. Craig Tendler of Mount Sinai's Department of Pediatric Hematology/Oncology.

Licensure/Certification:

	Board Certification in Internal Medicine: 2001
	New York State Medical License: active
	Florida State Medical License: active
	Board eligibility in Hematology and Oncology: Fall 2004

Personal:

	Married, one son (2 years old) and one daughter (2 months old)
	Interests include family time, and photographing my children